Quantcast
Last updated on April 18, 2014 at 15:44 EDT

Latest Personalized medicine Stories

2014-02-17 23:02:40

Transparency Market Research Report published "Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" to its database. Browse the full report with TOC at http://www.transparencymarketresearch.com/molecular-diagnostics-industry.html. Albany, New York, USA (PRWEB) February 17, 2014 According to a new market report published by Transparency Market Research “Molecular Diagnostics Market (PCR, Next Generation Sequencing,...

2014-02-17 08:25:02

SAINT-GENIS-POUILLY, France, February 17, 2014 /PRNewswire/ -- Highlights - HBM Healthcare Investments Ltd invests EUR20 million - The funds will be used to: - Accelerate the Company's international expansion, including an increased presence in the US - Finance the clinical development of its promising portfolio of innovative Molecular Nuclear Medicine diagnostic and therapeutic products...

2014-02-13 16:27:34

TUCSON, Ariz., Feb. 13, 2014 /PRNewswire/ -- The world's top scientific minds will convene at Tucson's Hilton El Conquistador Resort February 25 and 26 to collaborate and share leading-edge developments in cancer diagnostics and treatment. The 10(th) Annual Tucson Symposium puts Tucson at the leading edge of cancer research, diagnostics and treatment, and promises to further the field of personalized medicine and positively impact medical practice all over the world. Each year...

2014-02-11 08:31:08

WESTLAKE, Ohio, Feb. 11, 2014 /PRNewswire/ -- GenomOncology today announced a collaboration with Roswell Park Cancer Institute (RPCI) to develop an informatics solution that enables the association of Next Generation Sequencing results with knowledge resources to define actionable mutations. (Logo: http://photos.prnewswire.com/prnh/20140204/CL58248LOGO) "The challenges of translating the vast amounts of data from next-generation sequencing into a resource that can be easily and...

2014-02-07 08:24:01

DUBLIN, Feb. 7, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/bt6gxm/biomarkers_market) has announced the addition of the "Biomarkers Market - Discovery Technologies , Validation Services, Applications & Diseases - Global Trends & Forecasts (2013 - 2018)" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Biomarkers comprise definite cells, genes, molecules, gene products, enzymes, or hormones which are...

2014-02-06 08:27:18

ALBANY, New York, February 6, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Molecular Diagnostics Market (PCR, Next Generation Sequencing, Microarray, Infectious diseases, Genetic disease, Oncology testing, Blood donor screening) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global molecular diagnostics market was valued at USD 4.3 billion in 2012 and is expected to grow at a CAGR of...

2014-02-05 16:26:28

DUBLIN, February 5, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/r5d88l/molecular) has announced the addition of the "Concise Analysis of International Molecular Diagnostics in Genetic Testing" [http://www.researchandmarkets.com/research/r5d88l/molecular ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Molecular diagnostics in genetic testing brings advanced analytical techniques to...

2014-02-05 04:21:59

DUBLIN, February 5, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/3vvhng/global) has announced the addition of the "Global Personalized Medicine Diagnostics Market - Forecasts to 2016" [http://www.researchandmarkets.com/research/3vvhng/global ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) One of the main trends witnessed in the Global Personalized Medicine Diagnostics market is the...

2014-02-04 08:33:12

WESTLAKE, Ohio, Feb. 4, 2014 /PRNewswire/ -- GenomOncology today announced that the University of Pittsburgh has selected GenomOncology's GenomAnalytics(TM) platform and services to explore and mine the breadth of data that exists in The Cancer Genome Atlas (TCGA). (Photo: http://photos.prnewswire.com/prnh/20140204/CL58248LOGO) Cancer is a complex disease of the genome with each tumor having its own set of genetic anomalies. Increased understanding of the genetic changes in cancer...

2014-02-03 12:28:31

LONDON, Feb. 3, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Companion Biomarkers in Drug Development Companion biomarkers are diagnostic tests that are specifically linked to a therapeutic drug either during its development or in the clinic. This linkage can be an important component of the drug development process; alternatively, the companion biomarker can be useful in ameliorating the regulatory process for the drug, or acting as an aid to...